RV
Roche Venture Fund
Corporate VCActiveThe Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
91
Investments
3
Exits
—
AUM
3.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Roche Venture Fund.
Investment Thesis & Strategy
Roche Venture Fund invests in various stages of biotech and healthcare companies, leveraging Roche's industry expertise and resources to support innovation and strategic alignment.
Investment Activity
Deals per year over the last 7 years
1
20152
20166
20171
20180
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 91 companies
C
Cellares
Biotech · Series C+, 2021
T
Tessera Therapeutics
Biotech · Series B, 2021
V
Vaxcyte
Biotech · Series B, 2018
H
Hookipa Pharma
Biotech · Series B, 2017
I
Inari Medical
Healthcare · Growth, 2017
O
Obsidian Therapeutics
Biotech · Series B, 2017
P
Poseida Therapeutics
Biotech · Series B, 2017
A
Alector
Biotech · Series B, 2017
i
iTeos Therapeutics
Biotech · Series B, 2017
A
AM Pharma
Biotech · Series B, 2016
S
Scholar Rock
Biotech · Series B, 2016
D
Denali Therapeutics
Biotech · Series B, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
Good TherapeuticsAcquisition2024—
Spark TherapeuticsAcquisition2019$4.8B
Foundation MedicineAcquisition2018$5.3B
Frequently Asked Questions
Roche Venture Fund focuses on Series A, Series B stage investments.